Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Memory and Catch-up Vaccination with Synflorix in Children
NCT00950833Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2009
- Primary completion
- Sep 2010
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 3, open-label trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection and Haemophilus influenzae infection (3 arms), sponsored by GSK. Primary endpoint: Antibody Concentrations Against Vaccine Pneumococcal Serotypes. Started Aug 2009; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infectionHaemophilus influenzae infection
Beyond the preview
Go deeper on NCT00950833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00950833.